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Abstract: The α3β4 nAChRs are implicated in pain sensation in the PNS and addiction to 
nicotine in the CNS. We identified an α-4/6-conotoxin (CTx) TxID from Conus textile. The 
new toxin consists of 15 amino acid residues with two disulfide bonds. TxID was synthesized 
using solid phase methods and the synthetic peptide was functionally tested on nAChRs 
heterologously expressed in Xenopus laevis oocytes. TxID blocked rat α3β4 nAChRs with a 
12.5 nM IC50, which places it amongst the most potent α3β4 nAChR antagonists. TxID also 
blocked the closely related α6/α3β4 with a 94 nM IC50 but showed little activity on other 
nAChR subtypes. NMR analysis showed that two major structural isomers exist in solution, 
one of which adopts a regular α-CTx fold but with different surface charge distribution to 
other 4/6 family members. α-CTx TxID is a novel tool with which to probe the structure and 




Nicotinic acetylcholine receptors (nAChRs) are ligand-gated cationic channels that 
mediate fast synaptic transmission1 and are widely distributed throughout the peripheral and 
central nervous systems of both primitive and evolutionarily advanced organisms.  In 
addition, presynaptic nAChRs induce various brain regions to release several 
neurotransmitters, including dopamine, norepinephrine, serotonin, and acetylcholine. nAChRs 
are implicated in the pathophysiology of a number of disease states including epilepsy, 
Alzheimer’s disease, Parkinson’s disease and addiction.  
 The structures of nAChRs are highly conserved over a wide range of species from 
invertebrates to humans. This conservation is not only indicative of the important role that 
nAChRs play in the nervous system, but also provides an important platform for translational 
research from the in vitro discovery of selective ligands to their characterization in vivo in 
various animal models of human diseases.2 In mammals there are 16 different nAChR 
subunits, α1-7, α9, α10 and β1-β4, as well as γ, δ, and ε. These subunits assemble into 
pentamers to form a complex variety of nAChR subtypes with distinct pharmacological and 
biophysical properties. nAChRs containing the α3 subunit are present in autonomic ganglia 
and modulate cardiovascular functions. Nociceptive cells in the dorsal root ganglia express α3 
subunits and the corresponding α3* nAChRs are likely to modulate pain sensation.   
In the brain, the medial habenula expresses high nAChR levels.3 The habenula is 
involved in anxiety, fear and the response to stress. Recently, α3* nAChRs present in the 
medial habenula have attracted substantial attention because of their potential role in 
influencing nicotine addiction. Blockage of cholinergic signaling in the medial habenula leads 
to signs of nicotine withdrawal.4 Up- or down-regulation of nAChR function may influence 
the dose of nicotine that rodents will self-administer.5-6 Thus, strategies to selectively 
modulate α3* nAChR function are of considerable interest. 
Conotoxins are peptides from the venom of the Conus genus of predatory marine snails; 
many of these toxins are potent antagonists of a range of ion channels, transporters and 
membrane receptors.7-8 α-Conotoxins (α-CTxs) are amongst the smallest of the conopeptides ( 
12-20 amino acid residues) and act as nAChR antagonists. The selectivity of α-CTxs isolated 
from different Conus species can vary markedly, thus enabling dissection of the functional 
roles of nAChR subtypes.  
Defining the precise role of α3* nAChRs in normal and pathophysiological function has 
been hampered by the paucity of specific molecular probes. α-CTx AuIB from Conus aulicus 
has often been used, but its low potency has limited its use in physiological studies.9 The 
current study characterized a novel α-CTx from Conus textile. This peptide is the most potent 
α-CTx for α3β4 nAChRs yet reported, and represents a novel tool with which to probe the 
structure and function of α3β4 nAChRs. 
 
■ RESULTS 
DNA cloning and sequence analysis of the α-CTx TxID precursor. Each of the ~700 
species of cone snail produces a unique, complex complement of venom peptides. The genes 
encoding these peptides may be grouped into superfamilies based on a highly conserved 
signal sequence. Within a superfamily, peptide families are defined by the arrangement of 
cysteines in the primary toxin sequence that is generally indicative of the peptide’s ion 
channel target. In particular, the genes that encode α-CTxs show substantial conservation 
among all Conus species.10-11 An intron that precedes the toxin sequence and the 3′ 
untranslated region are highly conserved. Primers were designed based on the conserved 
intron and 3′ untranslated region sequences and used to PCR-amplify the toxin-coding region 
of an α-CTx gene in Conus textile. A 170 base pair sequence was identified that encodes a 16 
amino acid toxin region (EMBL accession number HF543950). A glycine is present at the 
C-terminal cleavage site that predicts amidation of a 15 amino acid mature toxin with the 
sequence GCCSHPVCSAMSPIC* (* = C-terminal carboxamide). The mature peptide is also 
 predicted to contain a cysteine pattern common to α-CTxs (CC-C-C). In contrast, the amino 
acid residues contained within the cysteine loops are unique, and are particularly divergent in 
the second cysteine loop compared to other known α-CTxs (Fig 1A and Table 1). 
 
Chemical Synthesis and Oxidative Folding of α-CTx TxID. The predicted peptide was 
synthesized in a linear form using Fmoc chemistry (Fig. 1A, Table 2). The peptide had two 
sequential Cys residues near the N-terminus followed by two additional Cys residues. These 
four Cys residues may theoretically be connected in three different disulfide bond 
arrangements, although bridging of the vicinal Cys is less common in native peptides. 
Previously characterized α-CTxs purified from venom have a disulfide bond connectivity that 
links the first Cys to the third Cys and the second Cys to the fourth Cys.12 We therefore 
synthesized α-CTx TxID with a bridging pattern of CysI-III and CysII-IV using directed 
two-step folding (Fig. 1B). We protected the cysteine side chains with two orthogonal 
protecting groups that can be removed selectively under different conditions, thus allowing 
the sequential formation of each disulfide bridge. S-trityl-protected cysteine was used for 
Cys2 and Cys8 and S-(acetamidomethyl) cysteine was used for Cys3 and Cys15. The acid 
labile S-trityl groups were removed first during cleavage from the resin while ferricyanide 
was used to close the disulfide bridge. The monocyclic peptide was purified by reverse-phase 
HPLC. Subsequently, the acid-stable acetomedomethyl groups were removed from the second 
and fourth Cys by iodine oxidation, which also closed the second disulfide bridge. The fully 
folded peptide was purified by HPLC with a retention time of 23.4 min (Fig. 1C). Laser 
desorption mass spectrometry (MALDI-TOF) of synthetic TxID was consistent with the 
presence of two disulfide bonds and an amidated C-terminus. TxID had calculated and 
observed monoisotopic masses of 1489.58 Da and 1489.5 Da, respectively. The synthetic 
peptide with the Cys2-Cys8 and Cys3-Cys15 disulfide bond arrangement was used in all 
subsequent studies (Fig. 1B). 
 
Effect of α-CTx TxID on ACh-evoked currents through nAChRs. The functional 
effects of synthetic TxID were tested on a range of nAChR subtypes. Combinations of 
nAChR subunits were heterologously expressed in Xenopus oocytes and the response to ACh 
measured. Fig. 2 shows representative responses to ACh of α3β4, α3β2, α4β4 and α7 nAChRs 
in the presence and absence of TxID. A complete block of ACh-evoked currents was obtained 
with 1 μM TxID on α3β4 nAChR (Fig. 2A) compared with little or no blocking of α4β4 (Fig. 
2B) α3β2 (Fig. 2C) and α7 (Fig. 2D) nAChRs by 10 μM TxID. The increased blockage of 
α3β4 nAChR activity by TxID was reversed within 4 minutes of toxin washout.  
In contrast, when a β2 rather than a β4 nAChR subunit was co-expressed with the α3 
subunit, the IC50 for TxID was more than 800-fold higher (Fig. 2B, Table 3), thus indicating 
that amino acid residue differences between the highly homologous β2 and β4 subunits 
significantly influence TxID toxin potency. Similarly, when an α4 rather than α3 nAChR 
subunit was co-expressed with the β4 subunit, the IC50 for TxID was also > 1000-fold higher, 
again indicating that amino acid residue differences between the homologous α3 and α4 
subunits significantly influence toxin potency (Fig.2 and Table 3). 
α-CTx TxID showed a dose-dependent block of α3β4 receptors at low nanomolar 
concentrations with an IC50 of 12.5 (9.4-16.5) nM (Fig. 2E, Table 3). The concentration 
 responses for TxID were subsequently assessed on each of the other expressed nAChR 
subtypes. α-CTx TxID was the next most potent on α6/α3β4 receptors with an IC50 of 94.1 
(73-121) nM. TxID showed only weak blockage of α2β4 receptors with an IC50 of 4550 
(3950-5230) nM. The IC50 for TxID was >10 μM for all other tested nAChR subtypes, 
including α3β2, α4β4, α4β2, α6/α3β2β3, α2β2, α9α10, α7, α1β1δε (Fig. 2B and Table 3). An 
ACh concentration-curve was performed on α3β4 nAChRs. Block of α3β4 nAChRs was then 
assessed in the presence of 10 µM TxID. With the addition of toxin to ACh, the magnitude of 
the maximum ACh response was reduced consistent with non-competitive block (Fig. 2F). 
 
NMR Spectroscopy. To determine the three-dimensional solution structure of TxID, 
one- and two-dimensional NMR spectra were recorded at 280, 298 and 308 K. Spectra in 10% 
D2O/90% H2O showed more than the expected number of peaks which suggested cis-trans 
isomerisation of one or both of the two proline residues, as reported previously for other 
α-conotoxins.13-16 A change of conditions to 30% d3-TFE/70% H2O at 308 K resulted in 
spectra showing two major species in a ratio of approximately 40:60. Isomer 1 was assigned 
as the trans-trans isomer due because of NOEs observed between the Hα i-1–HδPi protons of 
the Pro6 and Pro13 and their preceding residues. Cβ and Cγ chemical shifts were also used to 
assign both prolines as having trans peptide bond conformations.17 Full assignment was not 
possible for this isomer as no amide protons were observed in the NOESY fingerprint region 
for Gly1, Cys2 and Val7, although the sidechain protons of Cys2 and Val7 could be observed 
in other regions of the spectrum, as well as sequentially from the NH protons of their 
following residues. In contrast, isomer 2 showed greater dispersion in the amide fingerprint 
region and showed a complete cycle of Hαi–NHi+1 sequential connectivities, with the 
exception of the two proline residues (Pro6 and Pro13), which lack NH protons, and Gly1 at 
the N-terminus. Isomer 2 was determined to be a cis-trans isomer due to the lack of NOEs 
between Hα 5–Hδ6 protons and a large difference between the Cβ and Cγ chemical shifts of 
Pro6. 
   
 Structure Determination of TxID. Structure calculations were performed with CYANA 
using a torsion angle simulated annealing protocol. Distance and dihedral angle restraints 
were derived from the NOESY spectra and coupling constants, respectively. A set of 
structures consistent with the experimental data were calculated and the 20 lowest energy 
structures were chosen to represent the structural ensemble for each isomer (Fig. 3). A 
comparison of the structural statistics for each isomer is given in Table 4. Isomer 1 had a root 
mean square deviation (RMSD) of 0.48 ± 0.36 Å across backbone residues 2-15 and 
PROMOTIF 18 identified a short 3,10-helix spanning residues 8-10. In contrast, isomer 2 had 
an RMSD of 0.45 ± 0.25 Å and no secondary structural elements identified other than the two 
disulfide bonds.  
 
■ DISCUSSION AND CONCLUSION 
Cone snails hunt a variety of prey, including fish, mollusks and worms. They utilize 
nAChR antagonists as part of an arsenal of toxins to immobilize their prey. We identified a 
novel α-CTx encoded by a gene present in the mollusk-hunting Conus textile. The predicted 
mature toxin was synthesized and pharmacologically characterized. The peptide is most 
 potent on α3β4 nAChRs (12.5 nM IC50). α-CTx TxID is 7.5-fold less active on the closely 
related α6/α3β4 nAChR subtype and > 300-fold less active on all other tested nAChR 
subtypes (Table 2 and Table 3). α-CTx TxID is the most potent α-CTx antagonist of α3β4 
nAChR yet characterized and has a unique selectivity profile. 
The number of residues encompassed within the two loops (m, n) of α-CTxs is the basis 
for the division into several structural subgroups (m/n: 3/5, 4/3, 4/4, 4/5, 4/6 and 4/7). The 
loop-size roughly correlates with the pharmacological target selectivity. α-CTxs with a 3/5 
framework are generally isolated from fish-hunting snails and are active towards fish and/or 
mammalian neuromuscular nAChRs, whereas CTxs from the 4/3, 4/4, 4/5, 4/6 or 4/7 classes 
mainly interact with mammalian neuronal nAChRs.8 The most commonly reported 
framework is the 4/7 subgroup. Notably, the only other 4/6 peptide to be pharmacologically 
characterized is α-CTx AuIB, which was isolated from another mollusk-hunting cone snail, 
Conus aulicus.9 AuIB also targets the α3β4 nAChR, but is 60-fold less active than the α-CTx 
TxID characterized here. AuIB also shows activity towards the α7 nAChR subtype, a feature 
not shared by TxID.9,19-20 Other peptides isolated from worm- and fish-hunting Conus also 
show activity on α3β4 nAChRs, but lack the selectivity of α-CTx TxID. For example, an α4/7 
-CTx RegIIA from Conus regius venom potently blocks α3β2, α3β4 and α7 nAChRs. RegIIA 
at 1 μM completely inhibited α3β2, α3β4 and α7 nAChRs and inhibited α9α10 receptors by 
22%.21 In contrast, whereas 1 μM TxID completely inhibited α3β4, 10 μM TxID produced no 
inhibition of α3β2, α4β4, α7 and α9α10 nAChRs. The α4/4-CTx BuIA from the fish-eating 
snail Conus bullatus potently blocks numerous rat nAChR subtypes, with the highest potency 
for α3- and chimeric α6-containing nAChRs.22 The known related α-CTxs and their nAChR 
subtype selectivity preferences, including α3β4 nAChRs, are shown in Table 2.  
α-CTx TxID has an SHP-sequence in its first loop, which is present in several other 
α-CTxs that differ in their specificity for nAChR subtypes (Tables 1, 2), indicating that the 
selectivity of TxID is probably determined by residues present in its second loop. The second 
loop of TxID contains -SAMSP-, a sequence that is not found in other pharmacologically 
tested α-CTxs and that may be important for the toxin’s unique selectivity preference and 
potency towards the α3β4 nAChR subtype. The proline residue in the first loop of TxID is 
also noteworthy, as cis-trans isomerism at this residue might play a role in the overall 
conformation of TxID and related peptides, such as α4/6-AuIB, and α4/7-RegIIA, PeIA, PIA 
and Vc1.1 (Table 2). The NMR studies undertaken here showed that at least two structural 
isomers are present in TxID.  
In the present study we synthesized TxID with disulfide connections between 
CysI-CysIII and CysII-CysIV (Fig. 1B) to match the disulfide configuration of native 
conotoxins isolated from venom. We note, however, an interesting report20 that indicated that 
the ribbon (non-native) isomer of the α4/6 conotoxin AuIB exhibited a 10-fold increase in 
activity. It would be of interest to determine the activity of α-CTx TxID with CysI-CysIV and 
CysII-CysIII connectivity (i.e. ribbon isomer). 
α3β4 nAChRs are known historically for their roles in the autonomic nervous system. 
However, more recent studies suggest that they may have prominence in a number of CNS 
areas. α-CTxs have been used widely as pharmacological tools to characterize nAChRs. 
Studies with α-CTx AuIB suggested a role for α3β4 nAChRs in olfactory bulb neurogenesis23 
and the modulation of olfactory perceptual learning.24 Nicotinic activation increases the 
 frequency of spontaneous inhibitory postsynaptic currents in the basolateral amygdala by 
acting on α3β4-containing nicotinic receptors on GABAergic neurons and may play an 
important role in modulating synaptic transmission in the amygdala.25 Several studies suggest 
that the α3β4 nAChRs are present in medial habenula neurons and affect nicotine 
self-administration.26-27 In addition, the α3β4 combination may regulate glutamate release in 
hippocampal CA1 neurons.28 Norepinephrine release from hippocampal synaptosomes is 
sensitive to α-CTx AuIB,9 implying a nicotine-evoked norepinephrine release pathway that 
involves α3β4-containing nAChRs.29 Intrathecal administration of α-CTx AuIB into 
neuropathic rats reduced mechanical allodynia for up to 6 h without significant side effects, 
suggesting that α3β4 nAChR subunit-selective CTxs could be promising tools for examining 
the role of nAChRs in neuropathic pain.30  
NMR structural studies of TxID were complicated by the presence of two major 
conformational isomers, which increased the difficulty of solving the solution structure of this 
peptide in comparison to samples that contain a single isomer. Since these isomers cannot be 
separated and indeed, if they are separated would in any case equilibrate with each other, it is 
very difficult to identify which of the two isomers possesses the bioactive conformation, 
which is a limitation that we should explicitly point out here. Nonetheless, the use a 900 MHz 
spectrometer allowed us to successfully solve the structures of both isomers in solution. The 
structures of the two major conformational isomers indicated that one of them possesses the 
common α-helical motif that is found in a majority of other α-conotoxins characterized to 
date. 
As illustrated in Fig.4, an alignment of the lowest energy structures of the two 4/6 
conotoxins AuIB and TxID shows that the peptide backbone atoms overlay well, with an 
RMSD of 1.49 Å. Surface analysis reveals that, despite the sequence variation, the two 
peptides have a similar type of surface in terms of biophysical properties on one face and a 
different surface characteristic on the other face. Specifically, AuIB has a negatively charged 
Asp residue at position 14 whereas TxID has a hydrophobic Ile residue in the corresponding 
surface location. Given the similarities in fold, it would appear that this difference in surface 
properties is probably the reason for higher selectivity of TxID on α3β4 nAChRs. It will be of 
interest to test this hypothesis in future studies aimed at modulating the surface properties in 
this region. 
In summary, we discovered and characterized a novel α4/6-CTx TxID that potently 
blocks α3β4 nAChRs with a unique selectivity profile, showing the most potent (low 
nanomolar) blockage of α3β4 nAChRs so far. Thus, α-CTx TxID may be a valuable tool for 
elucidating the diverse roles of α3β4 nAChRs in a variety of normal and pathophysiological 
functions. 
 
■ EXPERIMENTAL SECTION 
Materials. Conus textile specimens were collected from the South China Sea off Hainan 
Province. Marine animal DNA Isolation Kit were purchased from Tiangen Biochemistry Ltd. 
(Beijing, China). The pGEM-T easy vector system were purchased from TaKaRa Ltd.(Dalian, 
China). A reverse-phase HPLC analytical Vydac C18 column (5μm, 4.6 mm × 250 mm) and 
preparative C18 Vydac column (10µm, 22mm×250mm) were obtained from Shenyue 
(Shanghai City, China). Reagents for peptide synthesis were from GL Biochem (Shanghai, 
 China). All other chemicals used were of analytical grade. Clones of rat α2-α7 and β2-β4, as 
well as mouse muscle α1β1δε cDNAs were kindly provided by S. Heinemann (Salk Institute, 
La Jolla, CA). Clones of β2 and β3 subunits in the high expressing pGEMHE vector were 
kindly provided by C.W. Luetje (University of Miami, Miami, FL). 
 
Identification and Sequencing of a genomic DNA clone encoding α-CTx TxID. 
Genomic DNA from the C. textile venom gland bulb was isolated using a marine animal DNA 
Isolation Kit (Tiangen Biochemistry Ltd. Beijing, China). The procedure followed the 
manufacturer’s suggested protocol for marine invertebrates as described previously.31 The 
resulting genomic DNA was used as a template for PCR using oligonucleotides tailed for 
cloning that corresponded to the 3′-end of the intron preceding the toxin region of α-CTx 
pre-propeptides and the 3′-UTR (untranslated region) sequence of the α pre-propeptides.32 
Final PCR amplification was performed with a cycling protocol composed of an initial 
denaturation at 94 °C for 7 min, 35 cycles at 94 °C for 30 s, 50 °C for 1 min, 72 °C for 2 min, 
and terminated with a final extension at 72 °C for 10 min. The purified PCR products were 
inserted into the pGEMT Easy vector via TA cloning (TaKaRa). Positive colonies 
transformed with conopeptide precursor DNA inserts were sequenced by Sangon Ltd.  
 
Chemical synthesis of TxID. TxID was assembled on an amide resin by solid-phase 
methodology using an ABI 433A peptide synthesizer and FastMoc (N-(9-fluorenyl) 
methoxycarbonyl) chemistry with standard side-chain protection, except for cysteine residues. 
Cys residues were protected in pairs with either S-trityl on Cys1 and Cys3, or 
S-acetamidomethyl on Cys2 and Cys4 (Fig. 1B). The peptides were removed from the solid 
support by treatment with reagent K (trifluoroacetic acid⁄water⁄ethanedithiol⁄phenol⁄ 
thioanisole; 90:5:2.5:7.5:5, v⁄v⁄v⁄v⁄v). The released peptide was precipitated and washed 
several times with cold ether. A two-step oxidation protocol was used to fold the peptides 
selectively as described previously.33 The monocyclic and bicyclic peptides were purified by 
HPLC on a reversed-phase C18 Vydac column using a linear gradient of acetonitrile (ACN): 
0–40 min 15–50% solvent B, 40-50 min 50–100% solvent B. Solvent B is 0.5% 
trifluoroacetic acid (TFA) in 90% acetonitrile with the remainder being water. Solvent A is 
0.65% TFA in H2O. Absorbance was monitored at 214 nm. The purity of the monocyclic and 
bicyclic peptides were determined by monitoring absorbance at 214 nm during HPLC HPLC 
(≥95% purity). Matrix-assisted laser desorption ionization (MALDI) time-of-flight mass 
spectrometry was utilized to confirm the identity of the products.  
 
Electrophysiology. Capped cRNA for the various subunits was made using the 
mMessage mMachine in vitro transcription kit (Ambion, Austin, TX) following plasmid 
linearization. cRNA of the α6/α3 chimera was combined with cRNA of high expressing β2 
and β3 subunits or β4 (in the pGEMHE vector) to give 200-500 ng/µl of each subunit cRNA. 
cRNAs of the other various regular subunits were combined to give 200-500 ng/µl of each 
subunit cRNA. Fifty nl of this mixture was injected into Xenopus oocytes as described 
previously, and incubated at 17 °C. Oocytes were injected within one day of harvesting and 
recordings were made 2-4 days post-injection. Oocytes were voltage-clamped and exposed to 
ACh and peptide as described previously.34 For screening of receptor subtypes and for toxin 
 concentrations of 10 μM and lower, once a stable baseline was achieved either ND-96 alone 
or ND-96 containing varying α-CTxs concentrations was manually preapplied for 5 min prior 
to agonist addition. All recordings were done at room temperature (~22 °C). 
ACh Concentration Response was determined by previously described methods. 35  
Briefly, to acquire ACh concentration-response data, a chamber constructed from a disposable 
200-μl polypropylene pipette tip with a length of 50 mm and an internal diameter of 0.5 mm 
at the upstream or intake end and 5 mm at the downstream or exhaust end. The chamber was 
perfused at a rate of ~2 ml/min. To introduce ACh into the chamber, the perfusion was halted 
for 10s and 20 μl of ACh was manually applied to the chamber via a small circular hole 
upstream from the oocyte. Upon resumption of perfusion (which was started immediately 
following the introduction of ACh into the chamber). This procedure was repeated with 
increasing concentrations ACh in the presence or absence of 10 µM toxin. with a time interval 
between applications of ACh of 50s. Responses were normalized to the response at 1 mM 
ACh which was defined as 100%. 
 
Data Analysis. The average of 5 control responses just preceding a test response was 
used to normalize the test response to obtain “% response.” Each data point of the 
dose-response curve represents the average ± S.E. of at least three oocytes. The dose-response 
data were fit to the equation: % response = 100/[1 + ([toxin]/IC50)^nH], where nH is the Hill 
coefficient, by non-linear regression analysis using GraphPad Prism (GraphPad Software, San 
Diego, CA).  
 
NMR spectroscopy. NMR spectra for TxID were recorded in 500 µL of either 10% 
D2O/90% H2O or 30% TFE/70% H2O (pH 3.5) on a Bruker Avance 600 MHz or a Bruker 
Avance-II 900 MHz NMR spectrometer. One-dimensional and two-dimensional NMR 
experiments, including TOCSY using a MLEV-17 spin lock sequence, NOESY, and 
DQF-COSY spectra were recorded at 280, 298 and 308 K. Chemical shifts were referenced to 
internal 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) at 0 ppm. The TOCSY and NOESY 
spectra were run with mixing times of 80 and 200 ms, respectively. Two-dimensional spectra 
were generally collected over 4096 data points in the f2 dimension and 512 increments in the 
f1 dimension over a spectral width of 12 ppm. Spectra were processed with Topspin (Bruker) 
and assigned using the program CCPNMR with the sequential assignment protocol.36 
 
Structure calculations. Distance restraints were derived from the NOESY spectrum 
using peak volumes. Dihedral angle restraints were determined from 3JHN-Hα coupling 
constants obtained from a one-dimensional 1H NMR spectrum. The phi angles were restrained 
to -100 ± 80° for 3JHN-Hα~ 7 Hz and -120 ± 30° for 3JHN-Hα >8 Hz. Structures were generated 
using CYANA37 and final structures were assessed using PROCHECK-NMR38 and 
PROMOTIF18. The 20 structures with lowest energy and best quality were chosen to represent 
the solution structure of each isomer of TxID. 
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■ Figure Captions 
 
 
Figure 1. α-CTx TxID pre-propeptide and encoded toxin (A), mature peptide sequence with a 
disulfide connectivity I–III, II–IV (B), and corresponding HPLC chromatograms (C) are 
shown (EMBL accession number HF543950). (A) A putative proteolytic processing site 1 (R) 
and amidation processing site 2 (G) are indicated by the arrow and the pro-region is in italics. 
The mature toxin region is underlined. The first glycine following the C-terminal cysteine in 
the mature toxin is presumed to be processed to a C-terminal amide in TxID. Cysteines are 
indicated in bold print. The stop codon is indicated by ◆. The deduced mature toxin sequence 
of TxID is GCCSHPVCSAMSPIC* (*, C-terminal carboxamide). (B) *, C-terminal 
carboxamide. (C) HPLC chromatograms of α-CTx TxID with a retention time of 23.4 min. 
The peptide was analyzed on a reversed phase analytical Vydac C18 HPLC using a linear 
gradient of 15% buffer B to 50% buffer B over 40 min, where A = 0.65% trifluoroacetic acid 
(TFA) and B = 0.5% TFA, 90% acetonitrile, and the remainder water. Absorbance was 
monitored at 214 nm. Inset in Figure 1C is MALDI-MS data for α-CTx TxID with observed 
monoisotopic mass of 1489.5 Da. 
 
Figure 2. The α-CTx TxID potently and selectively blocks α3β4 nAChRs. α-CTx TxID 
blocks α3β4 nAChRs (A) but has little or no activity at α4β4 (B), α3β2 (C) and α7 (D) 
subtypes. Xenopus oocytes expressing a given rat nAChR were voltage clamped at -70 mV 
and subjected to a 1 s pulse of ACh every minute as described in Experimental Procedures. A 
representative response in a single oocyte is shown. After control responses to ACh, the 
oocyte was exposed to 1 μM or 10 μM toxin for 5 min (arrow). The toxin was then washed 
out and the response to ACh was again measured. “C” indicates control responses to ACh. (E) 
Concentration response of α-CTx TxID on α3β4, α6/α3β4, α2β4 nAChR subtypes. Values are 
mean ± SEM from 3 to 8 separate oocytes. IC50 and Hill slope values are shown in Table 3. 
(F)  ACh-concentration-response curve for α3β4 nAChRs in the absence and presence of 10 
µM α-CTx TxID. Data were obtained in duplicate for each concentration from 3 separate 
oocytes. Responses were normalized to 1 mM ACh (defined as 100%). 
 
Figure 3. Ribbon representation of the lowest energy structures of α-conotoxin TxID. A, 
Isomer 1. B, Isomer 2. The N- and C-termini are labeled with N-ter and C-ter, respectively. 
The α-helical region between residues Cys8 and Ala10 is shown in red and yellow. Cysteine 
residues are labeled with Roman numerals and disulfide bonds are shown in blue. The 
structures were generated using the program MOLMOL.39 
 
Figure 4. Overlays and surface representations of TxID and AuIB. A, Overlays of TxID 
Isomer 1 (green) and AuIB (blue) (PDB code 1MXN). Lowest energy structures are aligned 
over the backbone atoms of residues from 2-15. Surface representation of B, TxID and C, 
AuIB. The negative residue (Asp) is shown in red, polar residues (Asn, His, Met, Ser, Thr and 
Tyr) are shown in grey, and hydrophobic residues (Ala, Ile, Phe, Pro, and Val) are green, 
 cystines are yellow, and glycines are cyan. The images on the right are rotated the 90° around 
the horizontal axis. Surface representations were generated using the program PYMOL. 
 
 Table 1.  Sequence alignment of TxID and related α-CTx precursors.  
 
 
Signal sequence is shaded. The pro-region is in italics. A putative proteolytic processing site (R or K) 
is indicated by the arrow. The mature toxin region is underlined. * , C-terminal amidation, the first 
glycine following the C-terminal cysteine in the mature toxin is presumed to be processed to a 
C-terminal amide for the corresponding toxin. Cysteines are indicated in bold print and framed. 
Dashes denote gaps
Precursor to Species Signal sequence                 Pro- region  ↓         mature region Reference 
αm/n Peptide 
α4/6 TxID C. textile       FDGRNAAGNDKMSALMALTTR↓ GCCSHPVCSAMSP-IC*G This Study 
AuIB C. aulicus MFTVFLLVVLATTVVSFTS       DRASDGRKDAASGLIALTMK↓     GCCSYPPCFATNP-DC*GRRR 9  
α4/4 BuIA C. bullatus MFTVFLLVVLTTTVVSFPS       DRASDGRNAAANDKASDVVTLVLK↓ GCCSTPPCAVLY---C*GRRR 22 
α4/3 RgIA C. regius SNKRKNAAMLDMIAQHAIR  ↓   GCCSDPRCRYR----CR 40 
α4/7 PeIA C.pergrandis FDGRNAAANDKASDLVALTVR↓ GCCSHPACSVNHPELC*G 41  
RegIIA C. regius MGMRMMGFTVFLLVVLTTTVVSSTS VRASDGRNAAADNRASDLIAQIVRR↓GCCSHPACNVNNPHIC* 21 
LtIA C. litteratus MGMRMMFIMFMLVVLATTVVTFTS  DRALDAMNAAASNKASRLIALAVR↓ GCCARAACAGIHQELC*GGGR 42 
MII C. magus MGMRMMFTVFLLVVLATTVVSFPS  DRASDGRNAAANDKASDVITLALK↓ GCCSNPVCHLEHSNLC*GRRR 34 
Vc1.1  C. victoriae MGMRMMFTVFLLVVLATTVVSSTS GRREFRGRNAAAKASDLVSLTDKKR↓ GCCSDPRCNYDHPEIC*G 43 

















a αm/n, α-CTxs subgroups (4/6, 4/3, 4/4, 4/7). 
b *, amidated C-terminal; y, sulfotyrosine; dashes denote gaps; amino acid conservation in the toxin sequences are denoted by shaded segments. 
c IC50, given IC50 values should only act as a rough guide with more detailed information available in the listed references. Most α-CTxs listed were tested on 
wide range of nAChR subtypes, however only the subtypes for which the peptide is selective and shows less than 10,000 nM potency are listed and ranked by 








TxID  C. textile GCCSHPVCSAMSP-IC* α3β4 (12.5 nM) > α6/α3β4 (94 nM) > α2β4 (4550 nM) This Study 
AuIB  C. aulicus GCCSYPPCFATNP-DC* α3β4 ( 750 nM) > α7 9 
Bu22 C. bullatus GCCTYPPCAVLSP-LCD N.D. 44 
TiIA C. tinianus GGCCSHPAC-QNNPDyC* N.D. 45 
α4/4 BuIA C. bullatus  GCCSTPPCAVLY---C* α6/α3β2β3 (0.26 nM) >α6/α3β4 (1.54 nM) > α3β2 (5.72 nM)> α3β4 (27.7 nM > α4β4 (69.9 nM) > α2β4 
(121 nM )> α7 (272 nM)>α2β2 (800nM )  
22 
α4/3 ImI  C.imperialis GCCSDPRCAWR----C* α3β2(41 nM) > α7(595 nM) >α9α10 (2000 nM) > α3β4 (3390 nM) 47 





RegIIA C. regius GCCSHPACNVNNPHIC* α3β2 (33 nM) > α3β4 (97 nM) > α7 ( 103 nM ) > α9α10 21 
PeIA C.pergrandis GCCSHPACSVNHPELC* α9α10 (6.9 nM) > α3β2 (23 nM) > α3β4 (480nM) > α7 (1800 nM) 41 
PIA  C.purpurascens RDPCCSNPVCTVHNPQIC* α6/α3β2β3 (0.95 nM) > α6/α3β4(30.5 nM)>α3β2(74.2 nM)> α3β4(518 nM) 32 
Vc1.1  C. victoriae GCCSDPRCNYDHPEIC* α9α10 (19 nM) > α6/α3β2β3 (140 nM) > α6/α3β4 (980 nM) > α3β4 (4200 nM) > α3β2 (7300nM) 47 
GIC  C.geographus GCCSHPACAGNNQHIC* α3β2 (1.1 nM) > α4β2 (309 nM) > α3β4 (755 nM) 32 
TxIB C. textile GCCSDPPCRNKHPDLC* α6/α3β2β3 (28.4 nM) 48  
 Table 3. IC50 and Hill slope values for block of various nAChR subtypes by α-CTx TxID. 
 
Subtypes IC50 (nM)a Ratio 
b Hill slope a Subtypes IC50 (nM) c 
α3β4 12.5 (9.4-16.5)  1 1.05 (0.66-1.44) α3β2 >10000 c  
α6/α3β4 94.1 (73-121) 7.5 1.30 (0.73-1.87) α2β2 >10000 c 
α2β4 4550 (3950-5230)  524 1.95 (1.48-2.42) α9α10 >10000 c 
α4β4 >10000 c  --  -- α7 >10000 c  
α4β2 >10000 c  --  --  Mα1β1δε >10000 c  
α6/α3β2β3 >10000 c --  --    
a Numbers in parentheses are 95% confidence intervals;   
b nAChR subtype IC50/α3β4 IC50 
c less than 50% block at 10-5 M. All receptors are rat except for α1β1δε, which is mouse. 
 
 Table 4.  Experimental and structural statistics for the 20 lowest energy structures of each 
TxID isomer 
 
 Isomer 1 Isomer 2 
Experimental data   
Distance restraints   
total NOE 102 105 
intra-residue 43 38 
inter-residue 59 67 
sequential (|i-j|) 41 50 
medium-range (|i-j|≤4) 18 10 
long-range (|i-j|≥5) 0 7 
Dihedral angle restraints, φ 6 10 
Total NOE violations exceeding 0.3 Å 0 0 
Total dihedral violations exceeding 2.0° 0 0 
   
Structure statistics   
Average pairwise rmsd (Å)   
backbone atoms (residues 2-15) 0.48 ± 0.36 0.45 ± 0.25 
heavy atoms (residues 2-15) 0.81 ± 0.38 1.13 ± 0.30 
Ramachandran statisticsa   
most favoured and allowed regions, % 95.4 98.3 
generously allowed regions, % 4.2 1.7 
disallowed regions, % 0.4 0 
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